Blogroll
|
Archive for the ‘Cannabis and Drug Testing’ Category
Wednesday, April 1st, 2009
The Substance Abuse and Mental Health Services Administration, or SAMHSA, is the Federal Government’s lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States. They have released the results of their 2007 Treatment Episode Data Set, or TEDS, showing the National Admissions to Substance Abuse Treatment Services. Let’s take a look at the statistics for marijuana, shall we?
 50% increase in marijuana treatment admissions in one decade
In 1997, about 200,000 people checked into treatment for marijuana. By 2005, that number has risen to over 300,000 people, though it has tapered off a bit these last couple of years. By any account, this is a huge rise in the number of people seeking rehab for marijuana in just a decade. It would seem like the powerful new “Not Your Father’s Woodstock Weed” has given rise to a 50% increase in reefer addicts!
 Only 15% of marijuana "addicts" admit themselves to treatment
However, when you look behind the numbers, you find that this increase has more to do with the rapid increase of drug courts in the late ’90s, early ’00s. By far, most of the people who are in treatment for marijuana are forced there! 57% are forced into treatment by the criminal justice system, while only 15% admitted themselves to treatment. For comparison’s sake, over all drugs combined, 1/3rd of all admissions are self-admissions, marijuana is the drug with the lowest self-admission rates (lower than meth) and highest criminal justice-admission rates (higher than meth), and for alcohol, self-admission is around 29% and criminal justice (including DUI) admissions are only 42.5%.
Full Story
Tags: Drug Courts, Drug Rehab, Drug Treatment, SAMHSA, TEDS Posted in Cannabis and Drug Testing, Cannabis and Health
Wednesday, December 24th, 2008

By Dale Gieringer, Ph.D, Director, California NORML
California NORML has recently heard increasing reports that Marinol patients are being drug tested and denied employment for use of marijuana. In particular, we have heard from legal Prop. 215 patients who were denied jobs despite presenting Marinol prescriptions after being re-tested specifically for marijuana. Until recently, Marinol and marijuana were indistinguishable on the standard drug tests, so that patients with a Marinol prescription had a valid medical excuse under federal law for testing positive for marijuana.
However, special testing techniques have been developed that make it possible to distinguish the two by testing for non-standard cannabinoids that appear in marijuana but not Marinol. Until recently, these tests were expensive and rarely used except in high-profile criminal cases. However, it appears that they are now being routinely used by certain laboratories in cases where Marinol use is claimed. In particular, we have heard reports of such testing being used to disqualify Marinol-using Prop 215 patients by the transportation industry and by Walmart.
California NORML has accordingly altered its drug testing information to warn against relying on Marinol RXs as a screen for marijuana use: http://www.canorml.org/healthfacts/testing.tips.html
There is of course no valid scientific or health justification for allowing patients to use Marinol but not marijuana. The only purpose is to enforce compliance with the law. It is a tribute to the power and influence of the drug testing industry that they have prevailed in foisting the costs of this unnecessary and obnoxious procedure on employers.
California NORML, 2215-R Market St. #278, San Francisco CA 94114
(415) 563-5858 / www.canorml.org
Tags: California NORML, cannabis, Dale Gieringer, drug testing, Marinol, medical cannabis, NORML, Prop. 215 Posted in Cannabis and Drug Testing, NORML board of directors, News
Wednesday, May 21st, 2008
Mainstream Media is Finally Catching On Regarding Law Enforcement Excesses and Human Tragedies Associated With Cannabis Prohibition
I spoke extensively last week with Willamette Weekly’s James Pipkin and on Monday with ABC’s Marcus Baram about NORML’s monitoring and gathering case examples from around the country where medical patients, notably medical marijuana patients, are being denied organ transplants. Marcus’ and James’ articles continue to cast more needed antiseptic light on this disturbing public health practice of official discrimination against otherwise lawful medical cannabis patients.


Heads up: Additionally, the Willamette Weekly has exposed the tragedy that confronts medical patients in Oregon — that no hospital in the state will perform organ transplants on patients who test positive for cannabis, even if they are in compliance with the state’s medical marijuana laws and are in the state’s medical marijuana patient registry.
Like the recent tragedy in Tallahassee regarding the tragic death of 23-year old Rachael Hoffman resulting from her being recruited as a ’snitch’ for the local narcotic officers, the general public and maybe more importantly the general news beat media (AKA, mainstream media) have started to really bore down hard on the human tragedies that arise daily from cannabis prohibition–both in criminal enforcement of the laws, as well as how the prohibition trends upwards into important public institutions, such as in the delivery of medicine to sick, dying or sense-threatened medical patients.
Via our voices, collective consciousness and continued effective uses of employing empowering communication mediums like the Internet (i.e., webpages, podcasts, blogs, online videos and active online social networking), we can advance the long held goal and belief that an informed general public is the best path forward to ending cannabis prohibition may now finally be upon us.
I was heartened to see the Ventura Star editorialize against denying medical marijuana patients access to organ donor banks.
As the saying goes: We are the ones we’ve been waiting for!
Let’s keep the collective pressure on the media, opinion and policy-makers to replace prohibition laws with viable, and common sense-based public policy alternatives.
Thanks to CA NORML’s Dale Gieringer, Ph.D and NLC member/2008 Aspen Legal Seminar faculty Doug Hiatt, Esq. for getting into the ABC news article!
Full Story
Tags: ABC News, medical marijuana, NORML, Oregon, organ transplants, Washington Posted in Cannabis and Drug Testing, NORML Executive Director, News, medical cannabis
Friday, May 2nd, 2008
Timothy Garon is dead. Why did he die?

The medical records will show that he died due to complications associated with massive liver failure. He would have likely survived longer if he received a timely organ transplant but was denied access because he followed his physician’s recommendation, used medical cannabis during his treatments for liver disease, therefore testing positive for THC metabolites and rather than receive the gift of a potentially longer life—instead doctors at the University of Washington deferred to federal prohibition laws and mores, handing Tim a death sentence.
There are no pharmacological or physiological reasons why Tim Garon, or any medical marijuana patient, should logically be denied access to life-saving or life-enhancing organ transplants.
In my view, commonsense and humanity were completely lacking here on the part of the doctors who denied Tim and his family a chance at a continued life together.
Full Story
Tags: cannabis, drug testing, medical marijuana, NORML, Tim Garon, University of Washington Posted in Cannabis and Drug Testing, Cannabis and Health, Cannabis and the Law, NORML Executive Director
|
Categories Recently Written
Monthly Archives
|